









Mercado
/
Acciones
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

5.995USD

+0.135+2.30%

Horarios del mercado （ET）Cotizaciones retrasadas 15 min

232.61MCap. mercado

PérdidaP/E TTM



Quanterix Corp

5.995

+0.135+2.30%

Descripción general Compañía Finanzas

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Información de la empresa

Símbolo de cotizaciónQTRX

Nombre de la empresaQuanterix Corp

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoDr. Masoud Toloue, Ph.D.

Número de empleados471

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 07

Dirección900 Middlesex Turnpike

CiudadBILLERICA

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal01821

Teléfono16173019400

Sitio Webhttps://www.quanterix.com/

Símbolo de cotizaciónQTRX

Fecha de salida a bolsaDec 07, 2017

Director ejecutivoDr. Masoud Toloue, Ph.D.

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

19.42K

+62.04%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.28K

-2.41%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Mr. Paul M. Meister

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

Por regiónUSD

Nombre

Ganancia

Proporción

North America

19.38M

64.01%

EMEA

6.63M

21.92%

Asia Pacific

4.26M

14.07%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

Estadísticas de accionistas

Actualizado: sáb., 2 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

Accionistas

Proporción

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor/Hedge Fund

30.87%

Investment Advisor

25.39%

Hedge Fund

12.76%

Individual Investor

6.60%

Research Firm

3.49%

Pension Fund

0.35%

Bank and Trust

0.21%

Family Office

0.13%

Venture Capital

0.05%

Other

20.15%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

391

37.62M

83.70%

-11.91M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

2023Q1

389

37.25M

100.03%

-8.36M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Columbia Threadneedle Investments (UK)

3.00M

7.72%

+237.57K

+8.60%

Mar 31, 2025

Portolan Capital Management, L.L.C.

2.96M

7.63%

+375.57K

+14.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.68M

6.91%

-89.03K

-3.21%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

6.5%

+316.41K

+14.32%

Mar 31, 2025

Kent Lake PR LLC

2.92M

7.53%

+279.82K

+10.58%

Mar 31, 2025

Walt (David R)

1.86M

4.79%

+370.00K

+24.84%

Jun 13, 2025

William Blair Investment Management, LLC

1.11M

2.85%

+43.96K

+4.14%

Mar 31, 2025

UBS Financial Services, Inc.

1.11M

2.87%

+186.90K

+20.14%

Mar 31, 2025

Easterly Investment Partners LLC

1.33M

3.41%

+370.63K

+38.81%

Mar 31, 2025

Invenomic Capital Management LP

902.04K

2.32%

+546.67K

+153.83%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

Invesco NASDAQ Future Gen 200 ETF

0.58%

iShares Micro-Cap ETF

0.06%

Fidelity Enhanced Small Cap ETF

0.04%

Avantis US Small Cap Equity ETF

0.03%

iShares Biotechnology ETF

0.02%

iShares Russell 2000 Value ETF

0.02%

Invesco RAFI US 1500 Small-Mid ETF

0.02%

Schwab U.S. Small-Cap ETF

0.01%

Proshares Ultra Russell 2000

0.01%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

Proporción0.58%

iShares Micro-Cap ETF

Proporción0.06%

Fidelity Enhanced Small Cap ETF

Proporción0.04%

Avantis US Small Cap Equity ETF

Proporción0.03%

iShares Biotechnology ETF

Proporción0.02%

iShares Russell 2000 Value ETF

Proporción0.02%

Invesco RAFI US 1500 Small-Mid ETF

Proporción0.02%

Schwab U.S. Small-Cap ETF

Proporción0.01%

Proshares Ultra Russell 2000

Proporción0.01%

ProShares UltraPro Russell2000

Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

